Corbus Pharmaceuticals listed on the stock exchange and received rating reports from various firms.
2 reports, 1 independent
Updated Sep 17
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Corbus Pharmaceuticals listed on the stock exchange and received rating reports from various firms.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Corbus Pharmaceuticals
company in Norwood, United States
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
Related events
- Cantor Fitzgerald and other analyst firms issued ratings on Amgen stock, which is listed on the Nasdaq exchange.
- Analyst ratings published on MarketBeat for Monopar Therapeutics, which trades on the Nasdaq stock exchange.
- Affirm listed on the Nasdaq stock exchange, filed disclosures with the SEC, and received research reports from Needham & Company.
- ProKidney and Cartesian Therapeutics were listed on the Nasdaq stock exchange and received ratings from MarketBeat.
- Citigroup provided analyst ratings and reports for ServiceTitan stock, which trades on Nasdaq.